Abstract Objective The European Society for Vascular Surgery (ESVS) has developed
clinical practice guidelines for the care of patients with aneurysms of the abdominal aorta …

Importance Endovascular aneurysm repair (EVAR) is the dominant treatment strategy for
abdominal aortic aneurysms, encompassing 80% of all repairs in the United States …

Objective To evaluate long term outcomes (reintervention and late rupture of abdominal
aortic aneurysm) of aortic endografts in real world practice using linked registry claims data …

Importance The US Food and Drug Administration (FDA) is building a national
postmarketing surveillance system for medical devices, moving to a “total product life cycle” …

Background Endoleaks represent the most common complication after EVAR. Some types
are associated with ongoing risk of aneurysm rupture and necessitate long-term surveillance …

Cardiovascular devices are essential for the treatment of cardiovascular diseases including
cerebrovascular, coronary, valvular, congenital, peripheral vascular and arrhythmic …

Objective Type III endoleaks after endovascular aneurysm repair (EVAR) of abdominal aortic
aneurysms (AAAs) with the Endologix unibody endograft remain a major concern, despite …

Objective To evaluate the risk for 90-day returns to care and long-term subsequent surgical
interventions after primary endovascular aneurysm repair (EVAR) with an Endologix AFX …

Background Clinical quality registries (CQRs) are intended to enhance quality, safety, and
cost reduction using real-world data for a self-improving health system. Starting in 2001 …

Purpose: To evaluate the influence of endograft fixation type on the incidence, treatment,
and outcomes of type III endoleaks (TIIIELs). Materials and methods: Abdominal aortic …